Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

ACRSACRS
Showing 5 of 13 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in ACLARIS THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 12.7M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $67.3M as of 2026-Q2. The position was increased (+87.0% shares). ACRS represents 0.6% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$67.3M

Current Shares

12.7M

Total Value Change

+$55.7M

Total Shares Change

+8.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.7M
+87.0%
$67.3M0.6%$5.29
65
2026-Q1
New
6.8M
-
$25.5M0.3%$3.04
47
2025-Q2
Exited
0
-100.0%
$00.0%$1.47
0
2025-Q1
Unchanged
4.7M
0.0%
$7.1M0.1%$1.59
0
2024-Q4
New
4.7M
-
$11.6M0.2%$2.48
46

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used